中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging

文献类型:期刊论文

作者Wang, Yaping1,2; Lin, Tingting1,2; Zhang, Wenyuan2; Jiang, Yifan2; Jin, Hongyue2; He, Huining1; Yang, Victor C.1,3; Chen, Yi2; Huang, Yongzhuo2
刊名THERANOSTICS
出版日期2015
卷号5期号:8页码:787-795
ISSN号1838-7640
关键词matrix metalloprotease protease-activatable probe tumor imaging brain tumor fluorescence resonance energy transfer
DOI10.7150/thno.11139
文献子类Article
英文摘要Tumor-associated proteases (TAPs) have been intensively studied because of their critical roles in cancer development. As a case in point, expression of matrix metalloproteases (MMP) is significantly up-regulated in tumorigenesis, invasion, and metastasis among a majority of cancers. Here we present a prodrug-type, MMP-2-responsive nanoprobe system with high efficiency and low toxicity for detecting MMP-2-overexpressed tumors. The nanoprobe system is featured by its self-assembled fabrication and FRET effect. This prodrug-type nanoprobe is selectively activated by MMP-2, and thus useful for detection of the MMP-2-overexpressed cells and tumors. The nanoprobe system works successfully in various animal tumor models, including human fibrosarcoma and subcutaneous glioma xenograft. Furthermore, in order to overcome the blood brain barrier (BBB) and achieve brain tumor targeting, a transferrin-receptor targeting peptide (T7 peptide) is strategically incorporated into the nanoprobe. The T7-functionalized nanoprobe is capable of detecting the orthotopic brain tumor, with clear, real-time in vivo imaging. This method is promising for in vivo detection of brain tumor, and real-time monitor of a TAP (i.e., MMP-2).
WOS关键词MATRIX METALLOPROTEINASE-2 ; NANOPARTICLES ; CANCER ; EXPRESSION ; GLIOMA
资助项目National Basic Research Program of China (973 Program)[2013CB932503] ; National Basic Research Program of China (973 Program)[2014CB931900] ; NSFC of China[91029743] ; NSFC of China[81172996] ; NSFC of China[81373357] ; NSFC of China[81361140344] ; NSFC of China[81422048]
WOS研究方向Research & Experimental Medicine
语种英语
出版者IVYSPRING INT PUBL
WOS记录号WOS:000354959900001
源URL[http://119.78.100.183/handle/2S10ELR8/276732]  
专题药物制剂研究中心
通讯作者Huang, Yongzhuo
作者单位1.Tianjin Med Univ, Sch Pharm, Tianjin Key Lab Technol Enabling Dev Clin Therape, Tianjin 300070, Peoples R China;
2.Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China;
3.Univ Michigan, Coll Pharm, Ann Arbor, MI 48108 USA
推荐引用方式
GB/T 7714
Wang, Yaping,Lin, Tingting,Zhang, Wenyuan,et al. A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging[J]. THERANOSTICS,2015,5(8):787-795.
APA Wang, Yaping.,Lin, Tingting.,Zhang, Wenyuan.,Jiang, Yifan.,Jin, Hongyue.,...&Huang, Yongzhuo.(2015).A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging.THERANOSTICS,5(8),787-795.
MLA Wang, Yaping,et al."A Prodrug-type, MMP-2-targeting Nanoprobe for Tumor Detection and Imaging".THERANOSTICS 5.8(2015):787-795.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。